60 related articles for article (PubMed ID: 9607098)
1. Antiherpetic activity of acyclovir is potentiated by mycophenolic acid.
Pancheva SN; Roeva IG; Remichkova MG
Acta Virol; 1997 Dec; 41(6):357-8. PubMed ID: 9607098
[No Abstract] [Full Text] [Related]
2. Mycophenolic acid as acyclovir partner for combined inhibition of herpes viruses.
Pancheva S; Roeva I; Dundarova D; Remichkova M
Pharmazie; 1999 Aug; 54(8):632-3. PubMed ID: 10483619
[No Abstract] [Full Text] [Related]
3. [Synergistic antiherpetic effect of combined administration of para-aminobenzoic acid and modified nucleosides].
Galegov GA; Akberova SI; Leont'eva NA; Stroeva OG
Biull Eksp Biol Med; 1997 Aug; 124(8):188-91. PubMed ID: 9410207
[No Abstract] [Full Text] [Related]
4. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
6. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiviral activity of Phyllanthus orbicularis extracts against herpes simplex virus type 1.
Fernández Romero JA; Del Barrio Alonso G; Romeu Alvarez B; Gutiérrez Y; Valdés VS; Parra F
Phytother Res; 2003 Sep; 17(8):980-2. PubMed ID: 13680841
[TBL] [Abstract][Full Text] [Related]
8. Spectral and biological characteristics of some Acyclovir salts.
Zaharia CN; Crişan I; Rojanschi D; Muţiu A
Rom J Virol; 1997; 48(1-4):61-9. PubMed ID: 9836328
[TBL] [Abstract][Full Text] [Related]
9. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.
Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
Antiviral Res; 2007 Feb; 73(2):147-50. PubMed ID: 16970995
[TBL] [Abstract][Full Text] [Related]
10. [The synthesis and antiherpetic activity of acyclovir phosphonate esters].
Ias'ko MV; Ulanova NIu; Andronova VL; Ivanov AV; Karpenko IL; Kukhanova MK; Galegov GA; Skoblov IuS
Bioorg Khim; 2004; 30(6):599-606. PubMed ID: 15586811
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
Ying C; De Clercq E; Neyts J
Antiviral Res; 2000 Nov; 48(2):117-24. PubMed ID: 11114413
[TBL] [Abstract][Full Text] [Related]
12. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
Weinberg A; Leary JJ; Sarisky RT; Levin MJ
J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.
Bencini M; Ranucci E; Ferruti P; Trotta F; Donalisio M; Cornaglia M; Lembo D; Cavalli R
J Control Release; 2008 Feb; 126(1):17-25. PubMed ID: 18079013
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
15. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
16. Main structural and stereochemical aspects of the antiherpetic activity of nonahydroxyterphenoyl-containing C-glycosidic ellagitannins.
Quideau S; Varadinova T; Karagiozova D; Jourdes M; Pardon P; Baudry C; Genova P; Diakov T; Petrova R
Chem Biodivers; 2004 Feb; 1(2):247-58. PubMed ID: 17191843
[TBL] [Abstract][Full Text] [Related]
17. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
